300 related articles for article (PubMed ID: 31108105)
21. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
[TBL] [Abstract][Full Text] [Related]
22. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
Matias I; Gonthier MP; Orlando P; Martiadis V; De Petrocellis L; Cervino C; Petrosino S; Hoareau L; Festy F; Pasquali R; Roche R; Maj M; Pagotto U; Monteleone P; Di Marzo V
J Clin Endocrinol Metab; 2006 Aug; 91(8):3171-80. PubMed ID: 16684820
[TBL] [Abstract][Full Text] [Related]
23. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
[TBL] [Abstract][Full Text] [Related]
24. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
25. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
26. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
van der Zijl NJ; Goossens GH; Moors CC; van Raalte DH; Muskiet MH; Pouwels PJ; Blaak EE; Diamant M
J Clin Endocrinol Metab; 2011 Feb; 96(2):459-67. PubMed ID: 21084401
[TBL] [Abstract][Full Text] [Related]
27. Methionine restriction prevents onset of type 2 diabetes in NZO mice.
Castaño-Martinez T; Schumacher F; Schumacher S; Kochlik B; Weber D; Grune T; Biemann R; McCann A; Abraham K; Weikert C; Kleuser B; Schürmann A; Laeger T
FASEB J; 2019 Jun; 33(6):7092-7102. PubMed ID: 30841758
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fiévet C; Staels B
Diabetes; 2006 Jun; 55(6):1605-13. PubMed ID: 16731822
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition.
Pinnick KE; Collins SC; Londos C; Gauguier D; Clark A; Fielding BA
Obesity (Silver Spring); 2008 Mar; 16(3):522-30. PubMed ID: 18239594
[TBL] [Abstract][Full Text] [Related]
30. Evolution of insulin resistance in New Zealand obese mice.
Veroni MC; Proietto J; Larkins RG
Diabetes; 1991 Nov; 40(11):1480-7. PubMed ID: 1936607
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.
Japtok L; Schmitz EI; Fayyaz S; Krämer S; Hsu LJ; Kleuser B
FASEB J; 2015 Aug; 29(8):3357-69. PubMed ID: 25911610
[TBL] [Abstract][Full Text] [Related]
33. Possible role of triacylglycerol-rich lipoproteins in the down-regulation of adipose obese mRNA expression in rats re-fed a high-fat diet.
Chang ML; Chen HL; Lu SC
J Biomed Sci; 2005; 12(4):621-8. PubMed ID: 16132107
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of type 2 diabetes susceptibility genes in the pancreatic islets, adipose tissue and liver of obese mice.
Morrison F; Locke J; Arif M; Murray A; Brown JE; Harries LW
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):413-9. PubMed ID: 23839539
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
[No Abstract] [Full Text] [Related]
36. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity.
Rossmeisl M; Rim JS; Koza RA; Kozak LP
Diabetes; 2003 Aug; 52(8):1958-66. PubMed ID: 12882911
[TBL] [Abstract][Full Text] [Related]
37. Increased adipose tissue expression of Grb14 in several models of insulin resistance.
Cariou B; Capitaine N; Le Marcis V; Vega N; Béréziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF
FASEB J; 2004 Jun; 18(9):965-7. PubMed ID: 15059968
[TBL] [Abstract][Full Text] [Related]
38. Deletion of CDKAL1 affects high-fat diet-induced fat accumulation and glucose-stimulated insulin secretion in mice, indicating relevance to diabetes.
Okamura T; Yanobu-Takanashi R; Takeuchi F; Isono M; Akiyama K; Shimizu Y; Goto M; Liang YQ; Yamamoto K; Katsuya T; Fujioka A; Ohnaka K; Takayanagi R; Ogihara T; Yamori Y; Kato N
PLoS One; 2012; 7(11):e49055. PubMed ID: 23173044
[TBL] [Abstract][Full Text] [Related]
39. Impaired regulation of hepatic fructose-1,6-bisphosphatase in the New Zealand obese mouse model of NIDDM.
Andrikopoulos S; Rosella G; Gaskin E; Thorburn A; Kaczmarczyk S; Zajac JD; Proietto J
Diabetes; 1993 Dec; 42(12):1731-6. PubMed ID: 8243819
[TBL] [Abstract][Full Text] [Related]
40. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
